Keyphrases
Age of Onset
6%
Alpha-synuclein (α-syn)
16%
Alzheimer's Disease
9%
Baboon
5%
Basal Ganglia
5%
Cervical Dystonia
9%
Confidence Interval
10%
D2 Receptor
7%
Deep Brain Stimulation
12%
Dementia
5%
Dopamine
9%
Dopamine D2 Receptor (DRD2)
5%
Dystonia
17%
Functional Magnetic Resonance Imaging
5%
Gait
5%
Huntington's Disease
21%
Idiopathic Parkinson's Disease
9%
Leucine-rich Repeat Kinase 2 (LRRK2)
5%
Levodopa
12%
Macaque
6%
Manganese
10%
Manganese Exposure
7%
Medicare Beneficiaries
5%
Monkey
5%
Movement Disorders
6%
Neurodegenerative Diseases
7%
Nonhuman Primate
13%
Odds Ratio
5%
Parkinson Patients
7%
Parkinson's Disease
100%
Parkinsonism
16%
Pathophysiology
6%
Patients with Parkinson's Disease
7%
Positron Emission Tomography
21%
Premanifest Huntington's Disease
5%
Radioligand
10%
Radiosynthesis
5%
Radiotracer
7%
Receptor Binding
7%
Regional Cerebral Blood Flow (rCBF)
6%
Striatal
10%
Striatum
6%
Subthalamic nucleus
5%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
8%
Tremor
5%
Unified Parkinson's Disease Rating Scale (UPDRS)
9%
Vesicular Acetylcholine Transporter (VAChT)
7%
Welders
5%
Neuroscience
Alzheimer's Disease
10%
Amyloid Protein
7%
Basal Ganglia
8%
Behavior (Neuroscience)
9%
Cerebellum
6%
Deep Brain Stimulation
15%
Dopaminergic
10%
Dystonia
18%
Fluorine-18
18%
Functional Magnetic Resonance Imaging
5%
Huntington's Disease
13%
In Vitro
8%
In Vivo
15%
L-DOPA
11%
Magnetic Resonance Imaging
5%
Neurodegenerative Disorder
7%
Parkinson's Disease
91%
Parkinsonism
14%
Positron Emission Tomography
23%
Positron Emission Tomography
12%
Putamen
7%
Radioligand
9%
Receptor
11%
Receptor Binding
7%
Spasmodic torticollis
7%
Stereotypic Movement Disorder
8%
Striatum
6%
Subthalamic Nucleus
10%
Synuclein
8%
Tremor
9%
Vesicular Acetylcholine Transporter
5%